A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
- Conditions
- Parkinson Disease
- Registration Number
- NCT00605163
- Lead Sponsor
- The Parkinson Study Group
- Brief Summary
The purpose of this study is to longitudinally follow consenting clinical trial participants who participated in PRECEPT (A Randomized, Double Blind, Placebo Controlled, Dose Finding Study to Assess the Efficacy and Safety of CEP 1347 in Patients With Early Parkinson's Disease). The study will assess the clinical and imaging outcomes relevant to the natural history of Parkinson's disease (PD), as well as determine early biomarkers of the disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 530
- Participation in the PRECEPT study
- Willing and able to give informed consent
- Patients will be excluded from participating in the the study if either of the criteria stated above is not met
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Unified Parkinson Disease Rating Scale (UPDRS) and β-CIT SPECT imaging of the dopamine transporter. Annual, ongoing assessments
- Secondary Outcome Measures
Name Time Method University of Pennsylvania Smell Identification Test (UPSIT) Annual, ongoing assessments
Trial Locations
- Locations (55)
Barrow Neurological Institute
🇺🇸Phoenix, Arizona, United States
Sun Health Research Institute
🇺🇸Sun City, Arizona, United States
University of Arkansas for Medical Sciences
🇺🇸Little Rock, Arkansas, United States
The Parkinson's & Movement Disorder Institute
🇺🇸Fountain Valley, California, United States
University of California Irvine
🇺🇸Irvine, California, United States
University of San Diego
🇺🇸La Jolla, California, United States
University of Southern California
🇺🇸Los Angeles, California, United States
Pacific Neuroscience Medical Group
🇺🇸Oxnard, California, United States
University of California Davis
🇺🇸Sacramento, California, United States
The Parkinson's Institute
🇺🇸Sunnyvale, California, United States
Scroll for more (45 remaining)Barrow Neurological Institute🇺🇸Phoenix, Arizona, United States